Balsalazide Disodium Capsule
Product Images NDC 50268-102

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Balsalazide Disodium (NDC 50268-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

A bar chart comparing the percentage of patients improved with two doses of Balsalazide (2.25 g and 6.75 g) across three measures: Stool Blood, Stool Frequency, and Sigmoidoscopy. The bars show higher improvement percentages for the 6.75 g dose with p-values indicating statistical significance (p=0.045, p=0.013, p=0.031). Sample sizes for each group range from 49 to 53 patients.*

FDA Label Image

Label 5026810313 Balsalazide 2017

Label for Balsalazide Disodium Capsules, USP, 750 mg by AvPAK. The label shows the product name, strength, and that it is Rx only. It indicates a package size of 30 capsules (3 x 10) unit dose. The label includes storage instructions, a barcode, and manufacturer information for AvKARE, Inc., Pulaski, TN.*

FDA Label Image

Structural-formula (Structural Formula)

Chemical structure of Balsalazide Disodium depicted with molecular components including aromatic rings, azo bond, carboxylate groups, and sodium ions, accompanied by two water molecules as hydrate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.